Publications by authors named "Daniel Binder"

Claim this Profile
F
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma.
Thierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, John V Catalano, Andrew Belch, Daniel Binder

Blood· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgM multiple myeloma with an extremely rare non-aggressive presentation: A case report.
Thomas Greuter, Martin Browne, Corina Dommann-Scherrer, Daniel Binder, Christoph Renner

Oncol Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
Lotfi Benboubker, Meletios A Dimopoulos, Angela Dispenzieri, John Catalano, Andrew R Belch, Daniel Binder

N Engl J Med· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging options for the management of non-small cell lung cancer.
Daniel Binder, Karin Hegenbarth

Clin Med Insights Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of vascular endothelial growth factor receptor-1 and -2 in normal and diseased canine eyes.
Daniel R Binder, Ian P Herring, Kurt L Zimmerman, J Phillip Pickett, William R Huckle

Vet Ophthalmol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker.
Daniel Binder, Ann-Christin Buckendahl, Ralf-Harto Hübner, Peter Schlattmann, Bettina Temmesfeld-Wollbrück

Med Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.
Daniel Binder, Ralf-Harto Hübner, Bettina Temmesfeld-Wollbrück, Peter Schlattmann

Cancer Chemother Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acremonium keratomycosis in a cat.
Daniel R Binder, Jesse E Sugrue, Ian P Herring

Vet Ophthalmol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of nasolacrimal fluorescein transit time in ophthalmically normal dogs and nonbrachycephalic cats.
Daniel R Binder, Ian P Herring

Am J Vet Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of weekly docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer.
Daniel Binder, Matthias Hackenthal, Lutz Graseck, Hans Schweisfurth, Christoph Schäper

J Thorac Oncol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
Ashraf Agaylan, Daniel Binder, Markus Sauer, Hannes Neuweiler, Oliver Meyer

Cancer· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of nonsurgical management and efficacy of demecarium bromide treatment for primary lens instability in dogs: 34 cases (1990-2004).
Daniel R Binder, Ian P Herring, Tobias Gerhard

J Am Vet Med Assoc· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of corneal anesthesia following topical administration of 0.5% proparacaine hydrochloride solution in clinically normal cats.
Daniel R Binder, Ian P Herring

Am J Vet Res· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial DNA depletion analysis by pseudogene ratioing.
Russell H Swerdlow, Gerard T Redpath, Daniel R Binder, John N Davis, Scott R VandenBerg

J Neurosci Methods· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of mtDNA depleted and repleted NT2 cell lines.
Daniel R Binder, William H Dunn, Russell H Swerdlow

Mitochondrion· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis